新年到来之际，美国制药公司上调了数百种药品价格，艾尔建(Allergan Inc., AGN)旗下20多种药品售价提高近10%。由于公众和政界就药价问题向制药行业施加更大压力，今年许多公司的提价幅度较为温和。不过，包括一些仿制药在内的少数药品提价幅度非常高。美国所开处方中有90%都是可替代品牌药的较低价仿制药。包括辉瑞制药有限公司(Pfizer Inc., PFE)最近恢复的提价在内，总体来看药价涨幅仍高于通胀率。据Rx Savings Solutions的分析显示，美国30多家制药商周二提高了数百种药品价格，平均涨幅为6.3%，包括同一种药品不同剂量的涨幅。Rx Savings Solutions出售的软件可以帮助雇主和医疗计划选择最便宜药品。
Pharmaceutical companies are ringing in the new year by raising the price of hundreds of drugs, with Allergan AGN setting the pace with increases of nearly 10% on more than two dozen products, according to a new analysis. Many companies’ increases are relatively modest this year, amid growing public and political pressure on the industry over prices. Yet a few are particularly high, including on some generics, the cheaper alternative to branded accounting for nine out of 10 prescriptions filled in the U.S. Overall, price increases, including recently restored price increases from Pfizer Inc., PFE 1.61% continue to exceed inflation. More than three dozen drugmakers raised the prices on hundreds of medicines in the U.S. on Tuesday, according to an analysis from Rx Savings Solutions, which sells software to help employers and health plans choose the least-expensive medicines. The average increase was 6.3%, according to the analysis, including increases on different doses for the same drug.
艾尔建证实了上述分析中提到的药品涨价，称该公司提高了51种药品的价格，其中27种涨价约9.5%，其余24种涨价约4.9%。涨价药品覆盖了该公司逾一半的产品组合，包括阿兹海默症治疗药物Namenda的延长释放版本以及干眼症治疗药物Restasis。根据此项分析，在上述公司涨价幅度超过9%的药品中，艾尔建的产品占最多数。
Pharmaceutical companies are ringing in the new year by raising the price of hundreds of drugs, with Allergan AGN setting the pace with increases of nearly 10% on more than two dozen products, according to a new analysis. Many companies’ increases are relatively modest this year, amid growing public and political pressure on the industry over prices. Yet a few are particularly high, including on some generics, the cheaper alternative to branded accounting for nine out of 10 prescriptions filled in the U.S. Overall, price increases, including recently restored price increases from Pfizer Inc., PFE 1.61% continue to exceed inflation. More than three dozen drugmakers raised the prices on hundreds of medicines in the U.S. on Tuesday, according to an analysis from Rx Savings Solutions, which sells software to help employers and health plans choose the least-expensive medicines. The average increase was 6.3%, according to the analysis, including increases on different doses for the same drug.
艾尔建证实了上述分析中提到的药品涨价，称该公司提高了51种药品的价格，其中27种涨价约9.5%，其余24种涨价约4.9%。涨价药品覆盖了该公司逾一半的产品组合，包括阿兹海默症治疗药物Namenda的延长释放版本以及干眼症治疗药物Restasis。根据此项分析，在上述公司涨价幅度超过9%的药品中，艾尔建的产品占最多数。
最新评论